Edition:
United Kingdom

Valeritas Holdings Inc (VLRX.OQ)

VLRX.OQ on NASDAQ Stock Exchange Capital Market

3.27USD
8:59pm GMT
Change (% chg)

$-0.28 (-7.89%)
Prev Close
$3.55
Open
$3.50
Day's High
$3.50
Day's Low
$2.90
Volume
5,084
Avg. Vol
6,550
52-wk High
$9.50
52-wk Low
$2.00

Chart for

About

Valeritas Holdings, Inc. is a commercial-stage medical technology company. The Company is focused on developing technologies for Type 2 diabetes. The Company's product, the V-Go Wearable Insulin Delivery Device (V-Go), is an insulin delivery device that helps patients with Type 2 diabetes requiring insulin to maintain their... (more)

Overall

Beta: --
Market Cap(Mil.): $19.02
Shares Outstanding(Mil.): 6.84
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 32.14 16.44
EPS (TTM): -- -- --
ROI: -- 14.01 10.62
ROE: -- 16.85 14.20

BRIEF-Valeritas Q3 revenue rises 4 pct

* Valeritas Holdings Inc - ‍gross margin increased to 39.8% during Q3 of 2017 as compared to 35.6% during same period in 2016​

08 Nov 2017

BRIEF-Valeritas Holdings files for sale of up to 3.35 mln shares of co's common stock

* Valeritas Holdings Inc files for sale of up to 3.35 million shares of co's common stock by selling stockholder aspire Capital Fund Llc‍​ - SEC Filing Source text: (http://bit.ly/2hMmTJN) Further company coverage:

04 Oct 2017

BRIEF-Valeritas Holdings files for mixed shelf of upto $20 mln

* Valeritas Holdings Inc files for mixed shelf of upto $20 million - SEC filing‍​ Source text for Eikon: (http://bit.ly/2hNk6jD) Further company coverage:

04 Oct 2017

BRIEF-Valeritas Holdings ‍enters into a common stock purchase agreement with Aspire Capital Fund

* Valeritas Holdings Inc - ‍Entered into a common stock purchase agreement ( "agreement") with Aspire Capital Fund LLC​

22 Sep 2017

BRIEF-Valeritas Holdings Inc Q2 loss per share $‍​1.83

* Qtrly loss per share $‍​1.83 Source text for Eikon: Further company coverage:

11 Aug 2017

Earnings vs. Estimates